FDA Inspection 1132998 — New York Blood Center Enterprises

New York Blood Center Enterprises — FEI 3005680856

The FDA completed an inspection of New York Blood Center Enterprises on November 5, 2020 in Port Jefferson Station, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 5, 2020
Fiscal Year
2021
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Port Jefferson Station, NY (United States)